Dextera Surgical’s MicroCutter 5/80™ & Cardiac Anastomotic Devices to Be Featured at the 31st Annual European Association...
October 09 2017 - 8:30AM
Business Wire
Dextera Surgical Inc. (Nasdaq: DXTR), a company developing and
commercializing the MicroCutter 5/80™ Stapler, today announced that
several leading surgeons will feature the use of Dextera Surgical’s
MicroCutter 5/80™ Stapler and its C-Port® Distal Anastomosis
Systems in three oral presentations at the 31st Annual European
Association for Cardio-Thoracic Surgery. The meeting is taking
place in Vienna, Austria October 7-11, 2017.
“We are extremely pleased to have both the MicroCutter and the
C-Port Systems highlighted in key presentations at EACTS, the
largest cardiothoracic surgery meeting in the world,” said Liam
Burns, vice president global sales and marketing of Dextera
Surgical. “We believe our presence at this important meeting, for
the fourth year in a row, validates the procedure-enabling nature
of the MicroCutter in uniportal approaches as well as the C-Port
System’s integral role during totally endoscopic coronary artery
bypass procedures.”
MicroCutter 5/80 Presentations
Davor Stamenovic, M.D., of St. Vincentius Hospital in Karlsruhe,
Germany will give two oral presentations highlighting the uses of
the Microcutter 5/80 during single-port video-assisted thoracic
surgery (VATS) procedures. The presentations will be as
follows:
- Tuesday, October 10 at 4:56 p.m. local
timePosterior uniportal video-assisted surgery for anatomical lung
resection
- Wednesday, October 11 at 9:50 a.m.
local timeUniportal video-assisted thoracoscopic anatomical left
upper lobe anterior (S3) segmentectomy
Dr. Stamenovic commented, “During lung procedures through a
single incision, space for surgical tools is at a premium. The slim
profile of the MicroCutter 5/80 provides critical visibility of the
targeted anatomy and the increased angulation enables near
perpendicular transection of the blood vessels. Neither the
visibility nor the articulation provided by the MicroCutter 5/80 is
available in any alternative stapling device.”
Cardiac Presentation
Husam H. Balkhy, M.D., of the University of Chicago Medicine,
presented the results of 265 totally endoscopic coronary artery
bypass (TECAB) procedures at his hospital.
- Sunday, October 8 at 2:48 p.m. local
timeRobotic totally endoscopic coronary bypass with distal
connectors: Mid-term outcomes at a single academic institution with
an experienced team
“I am excited to present the results from 265 patients who have
undergone robotic bypass procedures over the course of the last 3.5
years at a single academic institution,” said Dr. Balkhy. “The data
highlight significant improvement in patient outcomes defined by
shorter hospital stay and the ability to return to their normal
daily routine much more rapidly when compared to open heart
surgery. I believe studies like this are driving an increasing
interest in learning how to perform robotic procedures among my
fellow cardiac surgeons. Importantly, a critical tool for TECAB
procedure success is the C-Port Distal Anastomosis System, the only
available automated anastomosis tool, which reliably connects the
graft to the coronary artery making the totally endoscopic
procedural approach possible.”
MicroCutter Indication Information
The MicroCutter 5/80 Stapler and MicroCutter 30 White, Blue and
Curved Tip White and Blue Reloads are intended for transection and
resection in multiple open or minimally invasive urologic,
thoracic, and pediatric surgical procedures, as well as application
for transection, resection, and/or creation of anastomoses in the
small and large intestine, and the transection of the appendix. The
MicroCutter 5/80 Stapler and MicroCutter 30 White and Curved Tip
White Reloads may additionally be used in conjunction with open
solid organ parenchymal dissection techniques on veins four to five
millimeters in diameter and arteries three to seven millimeters in
diameter.
About the C-Port® Distal Anastomosis
Systems (C-Port systems)
In the United States, the C-Port Systems are intended for use in
the creation of anastomoses in blood vessels and grafts, including
use in coronary artery bypass grafting procedures. The C-Port
systems – the C-Port xA system and the Flex-A® system – can be
used on- or off-pump and create compliant anastomoses that expand
and contract with blood flow. The C-Port systems work on coronary
arteries as small as 1.3 millimeters in internal diameter and work
with grafts of various diameters and vessels with single wall
thicknesses less than 0.75 millimeters. The Flex-A system allows
surgeons to position the device to create a secure connection even
in difficult to reach areas of the heart.
About Dextera Surgical
Dextera Surgical designs and manufactures proprietary
stapling devices for minimally invasive surgical procedures. In the
U.S., surgical staplers are routinely used in more than one million
minimally invasive laparoscopic, video-assisted or robotic-assisted
surgical procedures annually.
Dextera Surgical also markets the only automated
anastomosis devices for coronary artery bypass graft (CABG) surgery
on the market today: the C-Port® Distal Anastomosis Systems and
PAS-Port® Proximal Anastomosis System. These products, sold
by Dextera Surgical under the Cardica brand name, have
demonstrated long-term reliable clinical performance for more than
a decade.
Forward-Looking Statements
The statements in this press release regarding the beneficial
use of the MicroCutter 5/80 and C-Port® Distal Anastomosis System
are "forward-looking statements." There are a number of important
factors that could cause results to differ materially from those
indicated by these forward-looking statements, including Dextera’s
need for additional funding, complications in the manufacturing
process may not be resolved in a timely manner, and the other risks
detailed from time to time in Dextera Surgical’s reports filed with
the U.S. Securities and Exchange Commission, including its
Quarterly Report on Form 10-Q for the quarter ended March 31,
2017, under the caption “Risk Factors.” Dextera Surgical expressly
disclaims any obligation or undertaking to release publicly any
updates or revisions to any forward-looking statements contained
herein. You are encouraged to read Dextera Surgical’s reports filed
with the U.S. Securities and Exchange Commission, available at
www.sec.gov.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171009005324/en/
Dextera Surgical Inc.Bob Newell, 650-331-7133Vice President,
Finance and Chief Financial
Officerinvestors@dexterasurgical.com